Videocapillaroscopic Findings in Hand Osteoarthritis
Key facts
- Who runs it
- Bandırma Onyedi Eylül University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 130 people, planned
- Starts
- 20 Nov 2026
- Expected to end
- 30 Apr 2027
- Type of study
- Observational, 2 groups
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patient group (Primary hand osteoarthritis); Being 18 years of age or older; Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations; Being willing to participate in the study and having signed the written Informed Consent Form; Being able to undergo clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations; Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system; Healthy control group
- Being 18 years of age or older
- Having no diagnosis of inflammatory rheumatologic disease or primary hand osteoarthritis
- Being willing to participate in the study and having signed the written Informed Consent Form
- Being similar to the patient group in terms of age and gender
- Being able to undergo nailfold videocapillaroscopy assessment
Who cannot take part
- Diagnosis of primary osteoarthritis of the hand or any inflammatory rheumatic disease
- Presence of hand pain or any chronic musculoskeletal disorder that affects hand function
- Patient group; Being under 18 years of age; Diagnosis of secondary osteoarthritis of the hand (due to trauma, infection, metabolic, or other causes); Presence of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, inflammatory myopathies, vasculitis, or other connective tissue diseases; History of Raynaud's phenomenon; History of malignancy; Chronic renal failure (stage 4-5) or advanced liver failure; Active infection or a serious infection within the last four weeks; Pregnancy or breastfeeding; History of a neurological condition that could affect hand grip strength (e.g., hemiplegia, tetraplegia, peripheral nerve injury, or other neurological/neuromuscular disorders resulting in loss of muscle strength); History of trauma, surgical intervention, or any procedure affecting the nail bed of the fingers within the last month; Presence of an open wound, active infection, severe dermatological condition, or deformity that would hinder the assessment of the nail fold; Refusal to participate in the study or failure to sign the informed consent form; Healthy control group; In addition to the exclusion criteria listed above:
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to compare microvascular changes-assessed via nailfold videocapillaroscopy-in patients with primary hand osteoarthritis against a healthy control group, and to investigate the relationship between capillaroscopic findings and disease severity, functional status, and clinical characteristics.
The 2 groups in the trial
- hand osteoarthritis group
hand osteoarthritis group; * Being 18 years of age or older. * Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations. * Being willing to participate in the study and having signed the written Informed Consent Form. * Being capable of undergoing clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations. * Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.
- control group
control group; * Being 18 years of age or older. * Absence of a diagnosis of inflammatory rheumatic disease or primary osteoarthritis of the hand. * Willingness to participate in the study and having signed the written Informed Consent Form. * Having characteristics similar to the patient group in terms of age and gender. * Being able to undergo the nailfold videocapillaroscopy assessment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Association of Nailfold Videocapillaroscopy Findings With Clinical, Functional, and Radiological Characteristics in Primary Hand Osteoarthritis: A Comparative Cross-Sectional Study With Healthy Controls
- Record updated
- 17 November 2026